VivoSim Labs, Inc.

VIVS

CIK 0001497253 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$26K
↑+8.3% +$2Kvs FY2024 (Q4)
Gross Profit
$26K
↑+18.2% +$4Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
41/100
  • Profitability
    0ROIC -141.4% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 3.25 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    0Asset Turnover 0.01x (1.0+ = capital-efficient)
  • Growth
    44Revenue YoY +8.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -10576.9% · trend +1319.8pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$0
investment in PP&E
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$7M
everything owned
Total liabilities
$3M
everything owed
Stockholders' equity
$4M
shareholder claim

Recent performance · 64 quarters

Revenue↑+8.3% +$2K
$26K
Net Income↑+21.9% +$756K
$-3M
Free Cash Flow
$0
Operating Margin↑+3873.1pts
-10576.9%

Drill down